Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.

@article{Steinberg2009OutcomeDW,
  title={Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.},
  author={Daniel H. Steinberg and Michael A. Gaglia and Tina L Pinto Slottow and Probal K Roy and Laurent Bonello and Axel de Labriolle and Gilles Lemesle and Rebecca L Torguson and Kimberly Kineshige and Zhenyi Xue and William O. Suddath and Kenneth M. Kent and Lowell F Satler and Augusto D. Pichard and Joseph Lindsay and Ron Waksman},
  journal={The American journal of cardiology},
  year={2009},
  volume={103 4},
  pages={491-5}
}
Drug-eluting stent (DES) implantation is the standard treatment for patients with bare-metal stent (BMS) in-stent restenosis (ISR) and is associated with low rates of target-vessel revascularization. Outcomes in patients with DES ISR treated using repeated DES placement are less certain. A total of 119 patients who presented with BMS ISR and 119 patients with DES ISR matched for baseline characteristics were evaluated. Both groups of patients were treated using DESs and compared with regard to… CONTINUE READING
42 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 42 extracted citations

Similar Papers

Loading similar papers…